MBL

Anti-FGFRL1 (Human) mAb

Product Code:
 
MBL-W321-3
Product Group:
 
Primary Antibodies
Supplier:
 
MBL
Host Type:
 
Mouse
Antibody Isotype:
 
IgG2b κ
Antibody Clonality:
 
Monoclonal
Antibody Clone:
 
9A1A10
Regulatory Status:
 
RUO
Target Species:
 
Human
Application:
 
Flow Cytometry
Shipping:
 
4°C
Storage:
 
-20°C
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
MBL-W321-3100 ul£345.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Applications:
FCM - 1-10 ug/mL
Background:
Fibroblast growth factor receptor-like 1, also known as FGFRL1 or FGFR-5, is a member of the fibroblast growth factor receptor (FGFR) family. FGFRL1 consists of an extracellular region composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment, and a cytoplasmic tyrosine kinase domain. The extracellular domain contributes to cell adhesion. FGFRL1 is expressed preferentially in cartilaginous tissues and is also expressed in the pancreas, liver, kidney, heart, brain, and skeletal muscle.
Formulation:
1 mg/mL in PBS/50% glycerol, pH 7.2
Gene IDs:
Human: 53834
Immunogen Translated:
Human FGFRL1 expressed Ba/F3transfectants generated from SST-REX (signal sequencetrap by retrovirus-mediated expression screening).
Reactivity:
This antibody reacts with human FGFRL1 on Flow cytometry.
Source:
This antibody was purified from hybridoma culture supernatant by Protein A affinity column chromatography.
Target:
FGFRL1 (Human)

Documents

References

1) Trueb, B., et al., J. Biol. Chem. 278, 33857-33865 (2003) 2) Kim, I., et al., Biochim. Biophys. Acta 1518, 152-156 (2001) 3) Wiedemann, M. and Trueb, B., Genomics 69, 275-279 (2000) 4) Kojima, T. and Kitamura,T., Nat. Biotechnol. 17, 487-490 (1999)